Clinical trial / 2013
High-dose B vitamins slowed gray matter atrophy in elderly adults with elevated homocysteine.
In a randomized controlled trial of elderly adults with mild cognitive impairment over two years, daily high-dose B vitamins (0.8 mg folic acid, 20 mg B6, 0.5 mg B12) slowed whole-brain shrinkage and reduced gray matter atrophy in Alzheimer-vulnerable regions up to sevenfold. This protective effect was restricted to participants with baseline homocysteine levels above 11 micromol/L. In that subgroup, B-vitamin therapy countered the rapid gray matter loss linked to elevated homocysteine.
- Study type
- Randomized controlled trial
- Who was studied
- Elderly adults with mild cognitive impairment
- What was measured
- Gray matter and whole brain volume atrophy
THE PAPER
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.
Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD. Proc Natl Acad Sci U S A, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.